RecruitingNCT06972225
Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.
Follow-up of MACE in Patients Treated With Drug-eluting Balloons Between 2010 and 2025; a Retrospective Study With Prospective Follow-up From an Institutional Database: EASY-drug-eluting Balloons
Sponsor
Olivier F. Bertrand
Enrollment
1,500 participants
Start Date
Jun 10, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Adults (>=18 years of age)
- Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025
- Identified in the institutional procedure database
Exclusion Criteria2
- Incomplete or non-available data on the post-procedural clinical follow-up
- Procedures where other devices were used in combination with drug-eluting balloons.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDEB
Use of DEB to treat coronary lesions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06972225
Related Trials
Prolonged Chest Tube Treatment to Reduce Rates of Atrial Fibrillation Following Cardiac Surgery
NCT068007811 location
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
NCT0695952446 locations
Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).
NCT067366656 locations
Artificial Intelligence Based Timing, Infarct Size and Outcomes in Acute Coronary Occlusion Myocardial Infarction
NCT069104361 location
FORWARD CAD IDE Study
NCT0666250034 locations